Alexandre Mérieux

This profile gathers the share dealings of Alexandre Mérieux in Biomerieux, where the filings describe the role as chief executive. In total, 12 filings cover trades dated from 4 October 2024 to 4 May 2026.

On the market, this insider has only ever bought: 5 purchases, €248.3M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants. In 2026 alone, the filings show 4 purchases and no sales.

Half of the purchases are above €54.5M and half below. Measured against the company's value, the median purchase equals 0.49% of market capitalisation, across 4 purchases where it is known. No cluster: in 3 purchases, no other insider of the company bought within 30 days. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +0.5%. This is a record of the past, not a forecast.

Most recently, on 5 May 2026, the filings show an open-market purchase worth €54.5M in Biomerieux. Filings reach the AMF feed a median of 4 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.